Methylergometrine maleate manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

methylergometrine maleate

Tablets, immediate release (IR) 0.2 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
Manufacturing Unit : GPI Regulated and Sold : Rx
Manufacturer #7499
Vertically integrated pharmaceutical manufacturer with four decades of experience producing high-volume Rx and OTC APIs, formulation intermediates, and finished tablets, capsules, and sachets. Core portfolio includes analgesics, anti-diabetics, and cardiovascular products spanning paracetamol, metformin, and ibuprofen. US FDA and EU-GMP approved facilities supply North America and Europe.

methylergometrine maleate

Injection 0.2 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, ANVISaudi Arabia, PICS, INVIMA, Saudi Arabia
Manufacturer #11735
Indian pharmaceutical manufacturer established in the 1980s with over four decades of experience producing Rx tablets, capsules, oral liquids, ointments, and eye drops. Exports to 80+ countries across Asia, Africa, Latin America, and CIS markets. Holds WHO-GMP, EU-GMP, PIC/s, ANVISA, COFEPRIS, and DIGEMID regulatory approvals.

methylergometrine maleate

Injection 0.2 mg/ml - 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303
A pharmaceutical manufacturer with over 25 years of experience that develops and produces fixed-dose and single-entity generic and specialty pharmaceutical products. The company offers an extensive range of injectable dosage forms, including parenterals, and also manufactures oral solids. Its facilities operate under recognised international quality certifications such as EU-GMP, ANVISA, PIC/S and TGA approvals, supporting reliable large-scale production of pharmaceutical products for global export while emphasizing efficacy, affordability and consistent quality.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.